Samsung Electronics has delivered a powerful signal that the artificial intelligence buildout is reshaping the memory-chip cycle, but its record quarter also raises a harder question for investors: whether extraordinary…
The Finance Herald
Hormel Foods is making a $1.055 billion bet that its next leg of growth will be served through restaurant kitchens rather than grocery aisles. The company agreed Wednesday to acquire…
Julius Baer has cleared a major regulatory obstacle, but the terms of its release show that Switzerland’s private bank still has years of supervised repair ahead. The Swiss Financial Market…
Jefferies Financial Group delivered record quarterly revenue in investment banking and equities, offering an early signal that the revival in dealmaking and stock-market activity is translating into substantial fees. But…
Armani has opened the door to bringing more than one investor into the 15% stake sale required by founder Giorgio Armani’s will, adding a new layer of flexibility to one…
U.S. business investment is sending a message that financial markets may not welcome: the economy’s most capital-intensive growth engine remains strong even as borrowing costs rise. New orders for nondefense…
Select Water Solutions is taking a major step to turn oilfield water management from a service business into contracted infrastructure. The company agreed Thursday to acquire privately held Pilot Water…
Paychex delivered higher revenue, wider margins and double-digit earnings growth in its fiscal first quarter. Investors sold the stock anyway. The reaction reflects a demanding question for the payroll and…
AutoZone’s fiscal fourth quarter gave investors two stories at once. The headline numbers were strong: net sales rose 5.6% to $6.59 billion, operating profit increased 10.1% to $1.3 billion, and…
The European Central Bank has moved tokenised finance out of the laboratory and into the euro area’s financial plumbing. On Monday, the Eurosystem launched Pontes, a service that allows wholesale…
Telix Pharmaceuticals is making a $1.65 billion bet that control over medical-isotope supply will matter more than near-term dilution. The Australian radiopharmaceutical company agreed Monday to combine with Germany’s ITM…